Card image cap

Lilly injects $450m into plant making Mounjaro

Eli Lilly is leaving nothing to chance when it comes to making the most of its fast-growing diabetes therapy Mounjaro – it is investing another $450million at a facility in North Carolina t

Card image cap
Partner Content

6th Obesity & NASH Drug Development Summit 2022

While investment in NASH has waned in the context of rigid histological endpoints and clinical setbacks, opportunities to target obesity and other metabolic disorders through the lens of a holistic